Piper Sandler Says To Buy Docusign (NASDAQ: DOCU) Even After JPMorgan Said To Sell

Wednesday, January 6, 2021 | Sam Quirke
Piper Sandler Says To Buy Docusign (NASDAQ: DOCU) Even After JPMorgan Said To SellIn what is shaping up to be 2021’s first battle of the sell side, Minnesota based investment bank Piper Sandler is going toe to toe with New York’s JPMorgan over the fate of Docusign (NASDAQ: DOCU). Considering their shares rallied nearly 300% in just nine months, it’s perhaps not too surprising that one of them would be out with a cautious note to end the year. But with us only a few days into 2021, the other has come out with an upgrade.

Halfway through last month, JPMorgan downgraded Docusign shares as part of a general cut to work-from-home stocks that had done tremendously well out of COVID-19 but whose best days might be behind them for the time being. The move came as momentum was picking up with the roll out of COVID vaccines, and hopes for a return to something like the old normal by the middle of 2021 were growing.

The End Of Work-From-Home Stocks?

In light of this kind of sentiment, the stocks that had performed the best because of COVID were always going to be vulnerable to portfolio reshuffling. Zoom Video (NASDAQ: ZM) are a great example of this; having come to represent for many the entire pandemic, both from a personal and professional point of view, their shares started falling in October and are currently down around 40% from those all time highs.

Docusign shares haven’t seen that kind of momentum swing just yet. While August did see them hitting all-time highs, that was very much a momentary spike in what was otherwise a fairly timid Q3 and Q4 for the San Francisco headquarter company. They did most of their rallying in the first half of the year and have spent the last six months consolidating their gains and have slowly but steadily started to march higher again.

Perhaps it’s this divergence from the likes of Zoom Video that has Piper Sandler excited about their prospects for 2021. On Tuesday of this week, they upgraded Docusign shares to Overweight, noting how the company’s pandemic-spurred upside is a "sustainable opportunity, in any environment." In a note to clients that was full of praise, they spoke to the company’s core e-signature product as being “at the heart of the digital transformation” that the COVID pandemic has accelerated.

Long Term Potential

Crucially for investors, both new and old, Piper Sandler believes “these strong trends will not reverse with any reopening, because DocuSign is at the forefront of a new normal regarding transactions." With a total addressable market of more than $50 billion and a somewhat limited field of competition, there’s plenty of reasons for Wall Street to be excited. Aside from these favorable fundamental factors, higher free cash flow margins also underpinned the upgrade.

As well as upgrading the stock, Pipe Sandler pushed their price target on shares up from $235 to $300, suggesting upside of more than 30% from current levels. Hitting this new target would also put shares above the top of August’s spike and confine that to history as an interesting spike on the chart rather than an all time high that has yet to be surpassed.

December’s Q3 earnings report had revenue up 50% on the year but GAAP EPS was slightly in the red. Considering they’re still waiting to turn a consistent profit, there’s an argument that shares are trading at some fairly frothy valuations. Indeed, this point made up much of JPMorgan’s decision to downgrade shares last month and it remains a risk. But this is a growth story to beat all growth stories and you’d be a contrarian to beat all contrarians to bet against Docusign’s continued march higher right now.

Piper Sandler Says To Buy Docusign (NASDAQ: DOCU) Even After JPMorgan Said To Sell

Featured Article: Market Perform



7 Semiconductor Stocks Set to Gain From the Chip Shortage

Who knew that something so tiny could create such a big problem? However, that’s the case with the semiconductor industry. Chip manufacturers are facing supply chain disruptions due to the Covid-19 pandemic.

Semiconductors are in high demand for the big tech companies who need the chips to power the servers for their data centers. But they are also needed for much of the technology we take for granted including laptops, tablets, mobile phones, gaming consoles, and automobiles – a sector that seems to be at the root of the current crisis.

Any weekend mechanic knows that even traditional internal combustion cars are heavily reliant on electronics. In fact, electronic parts and components account for 40% of a new, internal combustion vehicle. That’s more than doubled since 2000.

However as it turns out, some manufacturers may have overestimated how soon consumers would be ready for an “all-electric” future. And that meant that they didn’t forecast how much demand there would be for the kind of chips needed to do the mundane, but vital tasks of steering, braking, and even powering windows up and down.

Part of the problem is that U.S. businesses are heavily reliant on countries like China and Taiwan for their semiconductors. In fact, only about 12.5% of semiconductor manufacturing is done in the United States.

Of course, this creates a tremendous opportunity for the companies that manufacture these chips. And it comes at a good time. The semiconductor sector is notoriously cyclical and was coming down from the elevated demand for the 5G buildout.

In this special presentation, we’ll give you a list of seven semiconductor companies that you can invest in to take advantage of this opportunity.

View the "7 Semiconductor Stocks Set to Gain From the Chip Shortage".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
DocuSign (DOCU)1.9$195.28+0.9%N/A-165.49Buy$273.62
Zoom Video Communications (ZM)1.5$295.24+0.7%N/A378.51Hold$431.80
Compare These Stocks  Add These Stocks to My Watchlist 

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.